ArminLabs

What ArminLabs does

ArminLabs is a specialty medical diagnostics laboratory headquartered in Augsburg, Germany, operating under the legal entity Medicum Bad Aibling MVZ GmbH as part of the Sanecum Group network of medical laboratories. The lab focuses on the diagnosis of tick-borne diseases (primarily Lyme borreliosis and co-infections such as Babesia, Bartonella, Anaplasma, Rickettsia) and chronic or opportunistic infections. Its core test portfolio spans cell-based T-cell assays (EliSpot and iSpot measuring IFN-gamma and IL2 secretion), ELISA-based antibody screening (TickPlex Basic and Plus), microarray immunoblot (SeraSpot), immune status profiling (CD-Cells-Immunity measuring CD3+/CD56+/CD57+ NK cells), mycotoxin screening (ToxiPlex), and tick PCR analysis. A proprietary European patent (EP 2 199 303 A1) covers an advanced OspC antigen with over 30% improved specificity for Borrelia detection.

The lab operates a direct-to-patient and direct-to-doctor model: free test kits are ordered globally, blood samples are collected locally and shipped to the Augsburg lab, and results are emailed in English or German within 7-15 working days. Pricing is per-test with invoice payment within Germany and prepayment required internationally. The laboratory is triple-accredited under DAkkS (DIN EN ISO 15189:2024), CAP, and CLIA, and participates in interlaboratory comparison programs (INSTAND, RfB, ESfEQA, CAP). Marketing reaches an international audience through an eight-language website, social media channels, newsletters, and a 2026 conference circuit spanning Europe and the United States.

Name

ArminLabs

Legal name

Medicum Bad Aibling MVZ GmbH

Website

https://arminlabs.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

ArminLabs is a specialty medical diagnostics laboratory in Augsburg, Germany, offering T-cell, serological, and PCR-based testing for tick-borne and chronic infections to doctors, naturopaths, and patients globally.

Ownership category

akta.pro rank

Product category

Infectious Disease Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro industry

PRIMARYHLAFAMAB

Clinical Chemistry & Immunoassay Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAKAGAL

Tick-Borne & Vector-Borne Diseases

Healthcare & Life Sciences/Specialist Medical Practice/Infectious Disease

SECONDARYHLAGAEAB

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

SECONDARYHLAHAAAK

Autoimmune, Allergy & Specialized Immunology Diagnostics

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

SECONDARYHLAJAIAD

Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza)

Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks

Keywords

• Infectious disease diagnostics
• Tick-borne disease testing
• T-cell immune assays
• Lyme borreliosis testing
• Serological laboratory services

Headquarters

HQ city

Augsburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Laboratory Diagnostic Testing Services: ArminLabs provides diagnostic testing services for tick-borne diseases and chronic/opportunistic infections. Customers order free test kits and pay for the laboratory testing services. Results are delivered via email. Within Germany, payment is by invoice after receiving results. Outside Germany, prepayment via bank transfer or credit card is required.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

ArminLabs is a specialized diagnostic laboratory that performs advanced testing for tick-borne diseases and chronic/opportunistic infections, operating from Augsburg, Germany. The laboratory offers a comprehensive portfolio of diagnostic tests including T-cell assays (EliSpot/iSpot), ELISA-based antibody screening (TickPlex Basic and Plus), immunoblot microarrays (SeraSpot), PCR pathogen detection from ticks, immune status profiling (CD57+ NK cells), mycotoxin detection (ToxiPlex), and general serological tests. Test kits are shipped globally with samples analyzed at the Augsburg facility, serving patients, doctors, and naturopaths worldwide with reports delivered electronically.

Product overview

ArminLabs is a specialized medical diagnostics laboratory offering a comprehensive portfolio of diagnostic tests for tick-borne and chronic/opportunistic infections. The core offerings include EliSpot and iSpot (cell function T-cell tests detecting cellular immune responses), Tickplex Basic/Plus (ELISA-based antibody screening assays), SeraSpot MicroArray (immunoblot testing), CD-Cells-Immunity (immune status profiling), ToxiPlex (mycotoxin detection), Tick Test PCR (direct pathogen detection from ticks), and general serological tests (ELISA, IFT, immunoblot, immunoarray). The tests are performed using commercially available certified kits validated internally and externally, with accreditation under ISO 15189, CAP, and CLIA standards.

Differentiator

Problem solved

Functional benefit

Brands

• Tickplex: ELISA-based antibody screening assay for Borrelia and tick-borne pathogens, including Tickplex Basic and Tickplex Plus variants
• EliSpot/iSpot
• SeraSpot
• ToxiPlex
• CD-Cells-Immunity
• Tick Test

Products and services

• EliSpot T-cell-based diagnostic assay that measures IFN-gamma secretion from pathogen-specific activated T cells. The test detects cellular immune response for the previous 6-8 weeks and has sensitivity of 1 per 200,000 cells with specificity of 82-100%. Used for detecting Borrelia burgdorferi, Borrelia miyamotoi, Anaplasma/Ehrlichia, Bartonella henselae, Babesia microti, and other infections. Targeted at patients and healthcare professionals seeking T-cell-based diagnostic information.
• iSpot Advanced T-cell test that measures both IFN-gamma and IL2 secretion from activated T cells. IFN-gamma is associated with acute or active infection while IL2 represents the memory function of the immune system and convalescence. Offers improved differentiation between active infection and immunological memory compared to standard EliSpot. Targeted at healthcare professionals and patients requiring detailed T-cell activity profiling.
• Tickplex Basic Antibody screening ELISA assay for Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii. Combined IgM and IgG sensitivity of 100% with specificity of 90.2-96.4%, CE marked. Targeted at patients suspected of Lyme borreliosis and healthcare professionals screening for tick-borne bacterial infections.
• Tickplex Plus Comprehensive antibody screening assay enabling simultaneous determination of Borrelia burgdorferi sensu stricto, B. afzelii, B. garinii, Babesia microti, Bartonella henselae, Ehrlichia chaffeensis, Rickettsia akari, Coxsackievirus Type A16, Epstein-Barr virus, Human parvovirus B19, Mycoplasma fermentans and pneumoniae. Sensitivity approximately 95% and specificity 98%. Targeted at patients and doctors requiring comprehensive tick-borne and co-infection screening.
• SeraSpot MicroArray Modern immunoblot assay combining standardized ELISA technique with microarray analysis. Uses nanoliter-scale application of highly specific Borrelia burgdorferi antigens as spots on microtiter plate wells. Analyzes IgG and IgM antibodies against Borrelia burgdorferi subspecies including VlsE, p39, p58, p100, OspC, and DbpA. Targeted at doctors and patients needing confirmation of Borrelia exposure with lower susceptibility to errors than conventional Western Blot.
• CD-Cells-Immunity (CD57/NK cells)

Quantifiable outcome

• TickPlex Plus sensitivity: approximately 95%, specificity: 98%
• +5 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Sanecum GroupparentOthersArminLabs is part of the Sanecum Group, a network of medical laboratories. The legal entity operating ArminLabs is Medicum Bad Aibling MVZ GmbH, registered in the Sanecum Group. Eric Schwarzbach and Renate Douwes serve as managing directors of the parent company.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Synlab Group: Europe's largest medical diagnostics services provider operating reference labs across multiple countries including Germany. Provides broad clinical and specialty testing that overlaps with ArminLabs' menu at the high-volume tier.
• Cerba Healthcare: European reference laboratory network with specialty infectious disease testing capabilities across multiple geographies. Comparable specialty infectious disease menu and reference lab delivery model.
• Unilabs: Pan-European clinical and specialty reference laboratory with significant presence in Germany and other markets where ArminLabs serves customers. Comparable specialty and routine diagnostic menu.
• Sonic Healthcare: Global diagnostics provider with extensive European reference lab footprint including specialty infectious disease testing. Comparable regulatory-accredited reference lab model with broader geographic reach.

Direct peers

• Viracor Eurofins: Eurofins-owned specialty immunology and infectious disease reference lab offering T-cell, PCR, and serology panels for transplant and infectious disease. Comparable specialty infectious disease menu and reference-lab positioning.
• Galaxy Diagnostics: North Carolina specialty lab focused on Bartonella and other vector-borne infections using proprietary culture and PCR methods. Comparable niche specialty and HCP-targeted go-to-market.
• IMD Institut für Medizinische Diagnostik: Berlin-based specialty medical diagnostics laboratory offering a broad range of clinical chemistry, immunology, and infectious disease tests, and previous employer of ArminLabs' current Laboratory Medical Director. Directly comparable German specialty lab competitor.
• DNA ConneXions: Boulder, Colorado-based specialty lab offering PCR-based tick-borne disease testing (Borrelia, Babesia, Bartonella) direct-to-patient. Comparable niche focus and direct ordering model to ArminLabs.
• IGeneX Labs: California-based specialty reference lab focused on tick-borne disease diagnostics (Lyme, Babesia, Bartonella) using immunoblot, PCR, and T-cell approaches. Directly comparable niche, customer base, and esoteric test menu to ArminLabs.

Regional players

• MVZ Labor 28: Berlin-based specialty medical laboratory serving HCPs across Germany; comparable German specialty lab and prior workplace of ArminLabs' current Laboratory Medical Director.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/ArminLabs
• Facebookfacebook.com/arminlabs
• Instagraminstagram.com/arminlabs
• LinkedInlinkedin.com/company/arminlabs-gmbh

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ArminLabs